A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories
University of Copenhagen · Novo Nordisk Foundation · +10 more institutions
Abstract
Pancreatic cancer is an aggressive disease that typically presents late with poor outcomes, indicating a pronounced need for early detection. In this study, we applied artificial intelligence methods to clinical data from 6 million patients (24,000 pancreatic cancer cases) in Denmark (Danish National Patient Registry (DNPR)) and from 3 million patients (3,900 cases) in the United States (US Veterans Affairs (US-VA)). We trained machine learning models on the sequence of disease codes in clinical histories and tested prediction of cancer occurrence within incremental time windows (CancerRiskNet). For cancer occurrence within 36 months, the performance of the best DNPR model has area under the receiver operating…
Citation impact
- FWCI
- 67.18
- Percentile
- 100%
- References
- 60
Authors
25- DPDavide PlacidoCorresponding
University of Copenhagen, Novo Nordisk Foundation
- BYBo Yuan
Broad Institute, Harvard University, Dana-Farber Cancer Institute
- JXJessica Xin Hjaltelin
University of Copenhagen, Novo Nordisk Foundation
- CZChunlei Zheng
VA Boston Healthcare System
- ADAmalie Dahl Haue
University of Copenhagen, Novo Nordisk Foundation, Copenhagen University Hospital, Rigshospitalet
Topics & keywords
- Medicine
- Receiver operating characteristic
- Cancer
- Pancreatic cancer
- Disease
- Cancer registry
- Danish
- Machine learning
Funding
- UDU.S. Department of Defense
- AHAmerican Heart AssociationAward: 857078
- PCPancreatic Cancer Action Network
- LFLustgarten Foundation
- NNNovo NordiskAwards: NNF17OC0027594, NNF14CC0001
- NNNovo Nordisk FondenAwards: NNF14CC0001, NNF17OC0027594 and NNF14CC0001
- NINational Institutes of HealthAwards: U01 CA210171, P50 CA127003
- USUniformed Services University of the Health Sciences
- SUStand Up To CancerAward: SU2C#6180